Zobrazeno 1 - 10
of 16
pro vyhledávání: '"E R, Peskind"'
Autor:
L S, Schneider, D A, Bennett, M R, Farlow, E R, Peskind, M A, Raskind, M, Sano, Y, Stern, S, Haneline, K A, Welsh-Bohmer, J, O'Neil, R, Walter, S, Maresca, M, Culp, R, Alexander, A M, Saunders, D K, Burns, C, Chiang
Publikováno v:
The Journal of Prevention of Alzheimer's Disease.
The onset of mild cognitive impairment (MCI) is an essential outcome in Alzheimer's disease (AD) prevention trials and a compelling milestone for clinically meaningful change. Determining MCI, however, may be variable and subject to disagreement. Adj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f31944d1ab7d28d7be83e63ed4d8b73f
https://doi.org/10.14283/jpad.2022.72
https://doi.org/10.14283/jpad.2022.72
Autor:
Suzanne Craft, William J. Bremner, John K. Amory, E. R. Peskind, Sanjay Asthana, Alvin M. Matsumoto, M. A. Raskind, Monique M. Cherrier
Publikováno v:
Neurology. 64(12)
Objective: To determine the efficacy of testosterone (T) supplementation on cognition in a sample of men with Alzheimer disease (AD) or mild cognitive impairment (MCI).Methods: Fifteen patients with AD and 17 patients with MCI aged 63 to 85 years com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b515019b513f9c1c973490666445001
https://pubmed.ncbi.nlm.nih.gov/15985573
https://pubmed.ncbi.nlm.nih.gov/15985573
Autor:
A F, Clark, H T, Steely, J E, Dickerson, S, English-Wright, K, Stropki, M D, McCartney, N, Jacobson, A R, Shepard, J I, Clark, H, Matsushima, E R, Peskind, J B, Leverenz, C W, Wilkinson, R E, Swiderski, J H, Fingert, V C, Sheffield, E M, Stone
Publikováno v:
Investigative ophthalmologyvisual science. 42(8)
To examine the intracellular and extracellular expression of myocilin in the human and primate trabecular meshwork (TM) in the presence and absence of glucocorticoids.Myocilin expression was examined in cultured human TM cells by Northern blot analys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::30cf841b6903dd9fd8d229bb403a554c
https://pubmed.ncbi.nlm.nih.gov/11431441
https://pubmed.ncbi.nlm.nih.gov/11431441
Publikováno v:
The Journal of clinical endocrinology and metabolism. 86(2)
We have previously shown that when tested in the morning, older men and women, pretreated with metyrapone to block endogenous cortisol synthesis, exhibit delayed suppression of plasma ACTH in response to cortisol infusion. To confirm this finding and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9a7d7a01931c15a9391a75d5d130fd45
https://pubmed.ncbi.nlm.nih.gov/11158007
https://pubmed.ncbi.nlm.nih.gov/11158007
Publikováno v:
Neurology. 54(12)
Galantamine is a reversible, competitive cholinesterase inhibitor that also allosterically modulates nicotinic acetylcholine receptors. These mechanisms of action provided the rationale for a therapeutic trial of galantamine in AD.A 6-month, multicen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::123b37a4f52ccb7b89a6df3ae3e1b3b0
https://pubmed.ncbi.nlm.nih.gov/10881250
https://pubmed.ncbi.nlm.nih.gov/10881250
Publikováno v:
Journal of neurochemistry. 73(5)
Galanin (GAL) innervation is hypertrophied in the basal forebrain and cortex of patients with Alzheimer's disease (AD). Increased GAL could exacerbate the cognitive and behavioral deficits of AD because GAL acts as an inhibitory modulator of choliner
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::45d925f9762f0b4b3cd954e21b10686c
https://pubmed.ncbi.nlm.nih.gov/10537062
https://pubmed.ncbi.nlm.nih.gov/10537062
Autor:
E R, Peskind
Publikováno v:
The Journal of clinical psychiatry. 59
This article reviews placebo-controlled studies addressing drug efficacy for the cognitive deficits of Alzheimer's disease. Efforts to compensate for the presynaptic cholinergic deficiency in Alzheimer's disease by pharmacologically inhibiting acetyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e2856b1a7574a8706d2ff06d477b0984
https://pubmed.ncbi.nlm.nih.gov/9720483
https://pubmed.ncbi.nlm.nih.gov/9720483
Publikováno v:
Depression and anxiety. 7(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e1a40581663a57d9e0b1ef7a307ec26b
https://pubmed.ncbi.nlm.nih.gov/9656092
https://pubmed.ncbi.nlm.nih.gov/9656092
Autor:
E R, Peskind, J, Leverenz, M R, Farlow, R K, Ito, S A, Provow, R S, Siegel, M, Cleveland, C H, Morgan, M R, Pandian, S, Corbin, D, Nochlin, G D, Schellenberg, M A, Raskind, S L, Wagner
Publikováno v:
Alzheimer disease and associated disorders. 11(4)
The authors compared concentrations of soluble beta-amyloid protein precursor (s beta PP) in cerebrospinal fluid (CSF) in 45 patients diagnosed with probable Alzheimer disease (AD) and 26 normal older control volunteers. Soluble beta-amyloid protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5b8415bbd6fc1949aaac50be19956833
https://pubmed.ncbi.nlm.nih.gov/9437437
https://pubmed.ncbi.nlm.nih.gov/9437437
Publikováno v:
International journal of geriatric psychiatry. 12(10)
Most instruments that measure the impairments associated with Alzheimer's disease assess symptom severity. Little attention has been paid to the illness's impact on the time formal and informal caregivers spend caring for Alzheimer's individuals. A t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6d01eef83f270d8e2b955bdf111386e4
https://pubmed.ncbi.nlm.nih.gov/9395929
https://pubmed.ncbi.nlm.nih.gov/9395929